1. I. A. Volchegorskii, N. V. Mester, and O. G. Zotova, “Predictors of diabetic encephalopathy,” Zh. Nevrol. Psikhiat., 106, No. 9, 12–16 (2006).
2. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “Dynamics of the initial signs of experimental diabetic encephalopathy,” Ros. Fiziol. Zh., 99, No. 4, 491–500 (2013).
3. I. A. Volchegorskii and N. V. Mester, “Effects of antioxidants of the 3-hydroxypyridine group on depression in patients with diabetes mellitus,” Klin. Med., 2, 40–45 (2007).
4. R. S. McIntyre, J. K. Soczynska, J. Z. Konarski, and S. H. Kennedy, “The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms,” Expert Opin. Drug Saf., 5, 157–168 (2006), doi:
https://doi.org/10.1517/14740338.5.1.157
.
5. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “The insulin-potentiating activity of antioxidants in experimental diabetes mellitus,” Prob. Endokrinol., 56, No. 2, 27–35 (2010).